Baxter Expects To Roughly Double Renal Business By 2005 To $3.5 Bil.
This article was originally published in The Gray Sheet
Executive Summary
Baxter says it plans to approximately double the size of its renal business to $3.5 bil. annually by 2005, from $1.8 bil. in 2000, increasing the unit's annual growth rate to about 15% over the next several years from the current 9% level, the firm says.
You may also be interested in...
Aksys Projects $400 Mil. In PHD Hemodialysis System Revenues By 2006
Aksys expects PHD personal hemodialysis system revenues in the U.S. to reach approximately $400 mil. by 2006.
Baxter Web-Enabled Device Development Starting With Renal Dialysis
Baxter projects the growth rate of its renal business will accelerate to 15% "over the next several years" from its current growth rate of "10 to 12%" in part due to web-enabled devices under development.
Baxter Entering Alternate Care Market Via Sabratek I.V. Pump Line
Baxter is acquiring the majority of Sabratek's product lines, expanding the firm's infusion pump product portfolio to the alternate care market.